Shares of Cardio Diagnostics Holdings, Inc. (CDIO), an artificial intelligence-powered precision cardiovascular medicine company, are rising nearly 150% Tuesday morning following the launch of PrecisionCHD, a blood test for the early detection of coronary heart disease.
PrecisionCHD, a non-invasive test detects coronary heart disease with better than 75% sensitivity in both men and women. the company said.
CDIO is at $3.15 currently. It has traded in the range of $0.79-$10.25 in the last 1 year.
Source: Read Full Article
Lates News:
-
Fastenal Slips As Sales Miss Expectations
-
$ETH Had a Great July, Vastly Outperforming Bitcoin
-
JetBlue Sees Wider Than Expected Loss In Q4, Cuts FY23 Outlook; Stock Dips In Premarket – Update
-
Crawling Now, Sprinting Later: Analyst Foresees Major Bitcoin Rally
-
Bitcoin Heads Towards $30,000 As It Hits New Peak Despite Ongoing Market Woes